Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, semaglutide side effects last a few days to around two weeks after starting treatment or stepping up to a higher dose. Nausea is the most reported symptom and typically peaks in the first week, then fades as your body adjusts. These are prescription-only medicines, so a prescriber reviews your full picture before anything is dispensed. If side effects drag on beyond a few weeks or feel severe at any point, that is the moment to contact your clinical team rather than push through.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The questions our prescribers field most often in the first fortnight are some version of: "Is this normal?" It usually is. Semaglutide slows gastric emptying, which is precisely how it reduces appetite, and that same mechanism tends to produce nausea, a feeling of fullness that arrives quickly, and occasional loose stools in the early days. According to the NHS semaglutide patient information page, these gastrointestinal effects are among the most commonly reported, especially at the start of treatment.
For the majority of people, peak discomfort sits around days three to seven. Eating smaller portions, avoiding fatty or spicy food, and staying well-hydrated makes a practical difference. If you want a clearer picture of how long semaglutide side effects typically last for most people, our dedicated page walks through what the evidence shows. If you are still nauseated every day at week three on the same dose with no improvement, that is worth raising with your clinical team, not something to assume will eventually resolve on its own.
Fatigue, mild headache and burping are also reported in this phase. They are less talked about but noted on the Mounjaro and Wegovy SmPCs on the eMC and in trial data. Most people find these settle alongside the nausea.
Semaglutide for weight management follows a gradual titration schedule set by your prescriber, starting at 0.25 mg and moving up through 0.5, 1.0, 1.7 and 2.4 mg (with 7.2 mg now approved as a higher maintenance option). Each time the dose steps up, some people notice a brief return of nausea or loose stools for three to seven days. This is not a sign that the medicine is working less well or that something has gone wrong.
Think of it as the body re-calibrating. The same gradual-onset principle that applies at the start applies at each step. Understanding this ahead of time reduces the temptation to stop treatment at the precise moment when the body needs a little more time. A lot of people tell us they wish someone had flagged this before their second pen arrived.
If a particular dose causes side effects that simply do not settle (not just a rough week but ongoing significant disruption to daily life) your prescriber can review whether to hold at that dose longer before moving up. That decision belongs in a clinical conversation, not a forum. Our guide to Wegovy side effects more broadly covers the full profile across doses.
Most semaglutide side effects are an inconvenience rather than a danger, but a handful of symptoms need urgent attention rather than monitoring at home. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically flagging acute pancreatitis: severe, persistent stomach pain that spreads to the back, with or without vomiting, requires urgent medical assessment. Stop the injection and seek help promptly, do not wait to see whether it passes.
Other situations that warrant calling 111, your GP, or going to A&E include signs of serious dehydration (inability to keep fluids down for an extended period, dark urine, dizziness on standing), symptoms of an allergic reaction such as swelling of the face or throat, and any sudden change in vision if you have a history of diabetic retinopathy. You can read more about the longer-term side-effect picture for Wegovy if that is what is on your mind.
For non-urgent concerns between prescription reviews, our support team is available seven days a week. You are not expected to manage questions alone in between appointments.
A smaller number of people find that certain symptoms (constipation in particular) do not fully resolve with time the way nausea tends to. Constipation can actually increase as nausea settles, because gut motility slows at higher doses. Our page on which semaglutide side effects tend to last goes into more detail on this pattern and what tends to help. If it becomes a significant problem, your prescriber can suggest options.
Injection-site reactions (redness, itching, a small lump at the injection point) tend to be mild and are largely manageable by rotating sites each week, abdomen, thigh and upper arm are all suitable. For the precise storage and administration guidance that applies to your pen, the Patient Information Leaflet included with your medicine is the authoritative source; dose timing and storage windows vary and the leaflet should always be followed over anything read online.
If you are weighing up whether semaglutide is the right fit for you, our Wegovy overview covers the full licensed profile, including how long Wegovy side effects typically last at each stage of treatment, and the free consultation is where our prescribers work through suitability and side-effect risk with you individually, that conversation costs nothing and carries no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.